Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 189

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 189
---
;

●announcements by commercial partners or competitors of new commercial
                                            products, clinical progress or the lack thereof, significant contracts, commercial relationships
                                            or capital commitments;

●the introduction of technological innovations or new therapies
                                            that compete with our potential drugs;

●changes in the structure of healthcare payment systems;

●the impact of political instability and military conflicts, such
                                            as the conflicts and recent events in Ukraine and the Middle East, which has resulted in
                                            instability in the global financial markets and export controls; and

●period-to-period fluctuations in our financial results.

Moreover, the stock markets in general have experienced
substantial volatility that has often been unrelated to the operating performance of individual companies. These broad market fluctuations
may also adversely affect the trading price of our common stock. If the price of our common stock declines, our ability to raise funds
through the issuance of equity or otherwise use our common stock as consideration will be reduced. A low price for our equity may negatively
impact our ability to access additional debt capital. These factors may limit our ability to implement our operating and growth plans.

U.S. investors may have difficulty enforcing civil liabilities
against our directors or members of senior management.

Several of our officers and directors are non-residents
of the United States, and a substantial portion of the assets of such persons are located outside the United States. As a result, it
may be difficult to serve process on such persons in the United States or to enforce judgments obtained in U.S. courts against them based
on civil liability provisions of the securities laws of the United States. Even if a claimant is successful in bringing such an action,
there is doubt as to whether Australian courts would enforce certain civil liabilities under U.S. securities laws in original actions
or judgments of U.S. courts based upon these civil liability provisions.

Certain provisions of our amended and restated certificate of
incorporation may discourage, delay or prevent a change in control of our company and, therefore, depress the trading price of our securities.

Our amended and restated certificate of incorporation
provides that our board of directors is classified into three classes of directors, each with staggered three-year terms. This provision
may discourage, delay or prevent a merger, acquisition or other change in control that stockholders may consider favorable, including
transactions in which you might otherwise receive a premium for our securities.

In addition, as a Delaware corporation, we would
also generally be subject to provisions of Delaware law, including Section 203 of the Delaware General